Recommended Immunization Schedule for Adults Aged 19 Years or Older by Medical Conditions and Other Indications, United States, 2017
< < Back to Adult Immunization Schedule by Medical and Other Indications
These recommendations should be read with the footnotes and additional considerations.
* = Recommended for adults who meet the age requirement, lack documentation of vaccination, or lack evidence of past infection | § = Recommended for adults with additional medical conditions or other indications | • = Contraindicated | ⇒ = No recommendation |
Vaccine | Pregnancy 1-6, 9 | Immuno-compromising (excluding HIV infection)3-7, 11 | HIV infection CD4+ count (cells/µL) 3-7, 9-11 | Asplenia persistent complement deficiencies 7,10, 11 | Kidney failure, end-stage renal disease, on hemodialysis 7, 9 | Heart or lung disease, chronic alcoholism 7 | Chronic liver disease7-9 | Diabetes 7, 9 | Healthcare personnel 3,4, 9 | Men who have sex with men (MSM)6, 8, 9 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|
< 200 | ≥ 200 | |||||||||||
Influenza1 | 1 dose annually* | |||||||||||
Td/Tdap2 | 1 dose Tdap each pregnancy* | Substitute Tdap for Td once, then Td booster every 10 yrs* | ||||||||||
MMR3 | Contraindicated• | 1 or 2 doses depending on indication* | ||||||||||
VAR4 | Contraindicated• | 2 doses* | ||||||||||
HZV5 | Contraindicated• | ⇒ | 1 dose* | |||||||||
HPV–Female6 | ⇒ | 3 doses through age 26 yrs* | ⇒ | |||||||||
HPV–Male6 | ⇒ | 3 doses through age 26 yrs* | 3 doses through age 21 yrs* | 3 doses through age 26 yrs* | ||||||||
PCV137 | ⇒ | 1* | dose§ | |||||||||
PPSV237 | § | 1, 2,or 3 doses depending* | on indication§ | |||||||||
HepA8 | 2 or 3 doses§ | depending* | on vaccine§ | * | ||||||||
HepB9 | § | * | § | * | 3§ | doses* | ||||||
MenACWY or MPSV410 | § | 1 or more doses depending* | on indication§ | |||||||||
MenB10 | ⇒ | § | 2 or 3 doses* | depending on vaccine§ | ||||||||
Hib11 | ⇒ | 3 doses post-HSCT recipients only* | § | 1* | dose§ |
Page last reviewed: February 6, 2017
Page last updated: February 6, 2017
Content source: National Center for Immunization and Respiratory Diseases
Provided by: Centers for Disease Control and Prevention (CDC)